Načítá se...

Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Zhang, Zhonghan, Zhang, Yaxiong, Chen, Gang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Luo, Fan, Chen, Xi, Ma, Yuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Xue, Cong, Hou, Xue, Zhou, Ting, Ma, Shuxiang, Gao, Fangfang, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/
https://ncbi.nlm.nih.gov/pubmed/29330211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!